Recursion Pharmaceuticals (RXRX) EBIT Margin Growth (3y) (2023 - 2026)
Recursion Pharmaceuticals (RXRX) EBIT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -40,178.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 530.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | -140,977.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -140,977.00 |
| Dec 31, 2025 | 14,107.00 |
| Sep 30, 2025 | -285,210.00 |
| Jun 30, 2025 | -5,421.00 |
| Mar 31, 2025 | -24,814.00 |
| Dec 31, 2024 | -147,786.00 |
| Sep 30, 2024 | 145,408.00 |
| Jun 30, 2024 | 90,830.00 |
| Mar 31, 2024 | 49,143.00 |
| Dec 31, 2023 | 4,225.00 |
| Sep 30, 2023 | 124,746.00 |
| Jun 30, 2023 | 905,237.00 |
| Mar 31, 2023 | 3.00 Mn |